COVID Update: Masks are still required in health care settings, even if you’re fully vaccinated. Read our FAQs.

Updates in Heart Failure and Arrhythmias

About This Activity

Program Overview

Significant advances in the diagnosis and management of heart failure and arrhythmias continue to emerge, compelling the practice of cardiology to constantly evolve. These advances must be consistently implemented into clinical practice to guarantee the best care for patients affected by these cardiovascular conditions. Expert faculty will cover a wide range of topics including the diagnosis, management, and state-of-the-art treatment for heart failure, cardiac arrhythmias, and hypertension. Faculty will also cover a variety of co-morbid and chronic conditions patients with heart disease may face. The goal of this activity is for participants to return to their practice equipped with the latest evidence base and practical information to improve patient outcomes.

Educational Objectives

After completing this internet enduring material, participants should be able to:

  • Incorporate current and emerging clinical evidence in the assessment, treatment and management of patients with challenging cardiovascular disease.
  • Apply new concepts in the management of arrhythmias, heart failure and hypertension.
  • Identify gender disparities in cardiac device selection.
  • Assess device-based therapies for heart rhythm disorders.
  • Determine the effect of comorbidity and chronic conditions on patients with heart disease.
  • Outline best practices for the management of patients with atrial fibrillation.


Evidence-based Guidelines for Hypertension Management

Christian W. Mende, MD

Fostering Heart Failure Expertise and Clinical Competencies for Advanced Practice Providers

Kismet D. Rasmusson, DNP, FNP-BC

Intra-Atrial Shunts for the Treatment of Heart Failure

Rajeev C. Mohan, MD

Device Therapy Selection and The Role of Virtual Care for Heart Failure in 2021

Ajay V. Srivastava, MD

Panel Discussion/Q&A

Drs. Mende, Mohan, Rasmusson and Srivastava

Geriatric Considerations in the Management of Heart Failure and Arrhythmias

John A. Dodson, MD, MPH

Diabetes Treatment in Patients with Cardiovascular Disease and Heart Failure

Daniel Einhorn, MD

Obesity and Heart Disease: An Epidemic

Sunil Bhoyrul, MD

Panel Discussion/Q&A

Drs. Bhoyrul, Dodson, Einhorn and Mohan

Whirlwind Changes in Heart Failure: What You Need to Know for Your Patients

J. Thomas Heywood, MD

Lipoprotein(a) and Cardiovascular Disease

Calvin Yeang, MD, PhD


Gender Disparity in Cardiac Device Selection

Ulrika Birgersdotter-Green, MD

Panel Discussion/Q&A

Drs. Birgersdotter-Green, Heywood and Yeang

His Bundle Pacing

Gopi Dandamudi, MD, MBA

An Update on Left Atrial Appendage Occlusion for Stroke Prevention

Douglas N. Gibson, MD

What to Expect After an Afib Ablation

Nicholas Olson, MD

Recent Advances in Cardiac Monitoring, Pacing, and ICD Therapies

John D. Rogers, MD

Enduring Material Details

Released On

June 18, 2021

Expires On

December 17, 2021

Media Type

Internet enduring material

Completion Time

480 minutes / 8 hours

Credit Available

Maximum of 8 AMA PRA Category 1 Credit(s)™

Target Audience

This activity is intended for physicians and other health care practitioners who treat patients afflicted with cardiovascular disease and related co-morbidities.

Disclosure Policy

In accordance with the ACCME Standards for Integrity and Independence in Accredited Continuing Education, course directors, planners, moderators, faculty, and all others in control of the educational content of the continuing education activity must disclose all financial relationships with ineligible companies that they may have had within the past 24 months. If an individual refuses to disclose financial relationships, they will be disqualified from being a part of the planning and implementation of the activity. Owners and/or employees of an ineligible company with business lines or products relating to the content of the activity will not be permitted to participate in the planning or execution of any accredited program. All relevant financial relationships with ineligible companies listed for individuals in control of content have been mitigated. A complete listing of disclosures is below.


Role in Activity

Ineligible Company / Commercial Interest

Nature of Relevant Financial Relationship



  • None
  • N/A



  • Abbott, Medtronic, Inc.
  • Biotronik, Inc., Boston Scientific Corporation
  • Speaker, Research
  • Speaker



  • Abbott, Medtronic, Inc.
  • Biotronik, Inc.
  • Advisory Board, Consultant
  • Advisory Board



  • None
  • N/A



  • Abbott, Adocia, AstraZeneca, Boehringer Ingelheim, Corcept Therapeutics, Eli Lilly, Janssen, Novo Nordisk, Sanofi
  • AstraZeneca, Boehringer Ingelheim, DexCom, Eli Lilly, Janssen, Mylan, Novo Nordisk, Sanofi, Teva
  • Epitracker, GlySens, Intuity Medical
  • Abbott, Boehringer Ingelheim, Eli Lilly, Novo Nordisk
  • Advisor
  • Clinical Research
  • Medical Advisor
  • Speaker


Course Director, Moderator, Speaker

  • Abbott, Acutus, Biosense Webster, Inc., Boston Scientific Corporation
  • Consultant, Speaker, Proctor


Course Director, Speaker

  • Abbott, AstraZeneca, Boehringer Ingelheim, Novartis Pharmaceuticals
  • Abbott, ImpediMed
  • Medtronic, Inc.
  • Speaker
  • Clinical Research
  • Consultant



  • AstraZeneca, Bayer HealthCare, Boehringer Ingelheim, Janssen Pharmaceuticals, Lilly
  • Advisory Board, Speakers Bureau


Course Director, Moderator, Speaker

  • CORVIA, V-Wave
  • Research


Course Director, Speaker

  • Abbott, Johnson & Johnson
  • Abbott, Medtronic, Inc.
  • Medtronic, Inc.
  • Consultant
  • Speaker
  • Advisory Board



  • Novartis Pharmaceuticals
  • SC Pharmaceuticals
  • Speaker
  • Advisor


Course Director, Moderator, Speaker

  • Abbott, iRhythm, Medtronic, Inc.
  • Boston Scientific Corporation
  • Medtronic, Inc.
  • Consultant, Speaker
  • Speaker
  • Advisory Board


Peer Reviewer

  • None
  • N/A


Course Director, Moderator, Speaker

  • Abbott
  • Speaker



  • Ionis Pharmaceuticals, Kaneka Corporation
  • Research

CME Committee

CE approval, all final decision-making on activity

  • None
  • N/A

Scripps Conference Services & CME

Plan, manage, implement, and reconcile CE activities

  • None
  • N/A

Accreditation and Conflict of Interest Mitigation


Scripps Health is accredited by the ACCME to provide continuing medical education for physicians.


Scripps Health designates this internet enduring material for a maximum of 8 AMA PRA Category 1 Credit(s)™. Physicians should only claim credit commensurate with the extent of their participation in the activity.


Nurses and Nurse Practitioners

For the purpose of recertification, the American Nurses Credentialing Center accepts AMA PRA Category 1 Credit(s)™ issued by organizations accredited by the ACCME.


For the purpose of re-licensure, the California Board of Registered Nursing accepts AMA PRA Category 1 Credit(s)™ for attendance at structured learning activities offered by organizations accredited by the ACCME.


The American Academy of Nurse Practitioners Certified Program (AANPCP) and the American Association of Nurse Practitioners (AANP) accept AMA PRA Category 1 Credit(s)™ from organizations accredited by the ACCME.

Physician Assistants

PAs may claim a maximum of 8 Category 1 credits for completing this activity. NCCPA accepts AMA PRA Category 1 Credit(s)™ from organizations accredited by the ACCME.


Resolution of Conflicts of Interest (COI)

Scripps Health is required by ACCME to identify, evaluate, and mitigate all potential conflicts of interest. Scripps Health has identified and mitigated all COI prior to the start of this activity using a multi-step process including independent peer review of all presentations.

Event details

Content Available

Fri, Jun 18, 2021 - Fri, Dec 17, 2021

8 hours